v3 Template
M

Molecular Partners AG

Biotechnology / Healthcare Zurich-Schlieren, Switzerland and Concord, Massachusetts ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$20.0M
Funding Rounds
1
Last Funding
2024-10-25

About Molecular Partners AG

Molecular Partners is a biotechnology company focused on pioneering DARPin therapeutics to deliver unique therapies for cancer and other serious diseases. They aim to go beyond the limits of current leading treatments by developing innovative solutions like radiopharmaceuticals and immune cell engagers.

Products & Services

MP0533:A novel tetra-specific T cell engager targeting CD33 x CD123 x CD70 x CD3 for AML treatment.
MP0712:A lead Radio DARPin Therapy program targeting DLL3 for small cell lung cancer (SCLC) and neuroendocrine tumors (NETs).
Switch-DARPin Platform:A logic-gated platform for targeted and conditional activation of immune cells.
MP0317:A multispecific DARPin for tumor-localized immune activation targeting FAP x CD40 for solid tumor treatment.

Specialties

DARPin Therapeutics Radiopharmaceuticals Immune Cell Engagers Cancer Treatment Tumor-Localized Immune Activation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Offering
T: -
FT: Underwritten Offering 		A: 20000000
MR: -
FA: 20.0 million
FAN: 20000000 		D: 2024-10-25
FD: 2024-10-25 		1 investors
Underwritten Offering Latest
2024-10-25
$20.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Patrick Amstutz

Chief Executive Officer and Member of the Management Board, Member of the Board of Directors

A

Alexander Zürcher

Chief Operating Officer and Member of the Management Board

P

Philippe Legenne

Chief Medical Officer and Member of the Management Board

M

Michael Tobias Stumpp

EVP Projects and Member of the Management Board

R

Renate Gloggner

EVP People and Community and Member of the Management Board

R

Robert Hendriks

Senior Vice President, Finance

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Molecular Partners AG Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~360 employees (est.)
Locations
Zurich-Schlieren, Switzerland and Concord, Massachusetts
Zurich-Schlieren, Switzerland and Concord, Massachusetts, USA
Zurich-Schlieren, Switzerland and Concord, Mass., USA +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro